Muscle Weakness
2
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Defence TherapeuticsBC - Vancouver
1 programLow load resistance training with blood flow restrictionN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
Spine BioPharmaDepo-Medrol
Defence TherapeuticsLow load resistance training with blood flow restriction
Stimit AGNon-invasive electromagnetic stimulation
Clinical Trials (3)
Total enrollment: 108 patients across 3 trials
Depo-Medrol on Psoas After LLIF
Start: May 2023Est. completion: May 202780 patients
Phase 4Recruiting
Acute Physiological Responses to Twice Daily Blood Flow Restriction Training
Start: Nov 2023Est. completion: Sep 202418 patients
N/AUnknown
Electromagnetic Stimulation of the Phrenic Nerve in Critically Ill Mechanically Ventilated Patients (STIMIT-II)
Start: Jan 2022Est. completion: May 202210 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 108 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.